Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 29, 2022

50715_rns_2022-07-29_1cdf0f99-d225-4caa-a3fd-cc60b4b786ac.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

29 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase
/ Sale
Total
number of
shares
involved
Total amount
paid / received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
China International
Capital Corporation
Limited
28 July
2022
Other types
of securities
(e.g. equity
swaps)
Closing / flattening / unwinding
of proprietary positions arising
from unsolicited client-driven
dealings. I confirm this was
done no later than the close of
the morning trading session on
the trading day following the
orginating client-driven dealing
Sale 99,100 $3,686,711.7200 $37.2538 $37.1490

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Ordinary
shares
Closing / flattening / unwinding
of proprietary positions arising
from unsolicited client-driven
dealings. I confirm this was
done no later than the close of
the morning trading session on
the trading day following the
orginating client-driven dealing
Purchase 99,100 $3,686,900.0000 $37.5900 $36.9800

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.